Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria

Author:

Bonazzetti Cecilia12ORCID,Rinaldi Matteo12ORCID,Cosentino Federica2,Gatti Milo13ORCID,Freire Maristela Pinheiro4ORCID,Mularoni Alessandra5ORCID,Clemente Wanessa Trindade6,Pierrotti Ligia Camera7ORCID,Aguado Jose Maria8ORCID,Grossi Paolo9ORCID,Pea Federico13,Viale Pierluigi12,Giannella Maddalena12ORCID,

Affiliation:

1. Department of Medical and Surgical Sciences Alma Mater Studiorum University of Bologna Bologna Italy

2. Infectious Diseases Unit IRCCS Policlinico Sant'Orsola Department of Medical and Surgical Sciences University of Bologna Bologna Italy

3. Clinical Pharmacology Unit IRCCS Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy

4. Working Committee for Hospital Epidemiology and Infection Control Hospital das Clinicas Universidade de São Paulo Sao Paulo Brazil

5. Unit of Infectious Diseases IRCCS‐ISMETT Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione Palermo Italy

6. Department of Laboratory Medicine Faculdade de Medicina Universidade Federal de Minas Gerais Belo Horizonte Brazil

7. Immunosuppressed Infection Group Divisão de Moléstias Infecciosas e Parasitárias do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Sao Paulo Brazil

8. Unit of Infectious Diseases Hospital Universitario “12 de Octubre” Instituto de Investigación Sanitaria Hospital “12 de Octubre” (imas12), CIBERINFEC, Universidad Complutense Madrid Spain

9. Infectious and Tropical Diseases Unit Department of Medicine and Surgery University of Insubria‐ASST‐Sette Laghi Varese Italy

Abstract

AbstractBackgroundPerformance of active screening for multidrug‐resistant Gram‐negative bacteria (MDR‐GNB) and administration of targeted antibiotic prophylaxis (TAP) in colonized patients undergoing liver (LT) and/or kidney transplantation (KT) are controversial issues.MethodsSelf‐administered electronic cross‐sectional survey disseminated from January to February 2022. Questionnaire consisted of four parts: hospital/transplant program characteristics, standard screening and antibiotic prophylaxis, clinical vignettes asking for TAP in patients undergoing LT and KT with prior infection/colonization with four different MDR‐GNB (extended‐spectrum cephalosporin‐resistant Enterobacterales [ESCR‐E], carbapenem‐resistant Enterobacterales [CRE], multidrug‐resistant Pseudomonas aeruginosa [MDR‐Pa], and carbapenem‐resistant Acinetobacter baumannii [CRAb]).ResultsFifty‐five respondents participated from 14 countries, mostly infectious disease specialists (69%) with active transplant programs (>100 procedures/year for 34.5% KT and 23.6% LT), and heterogeneous local MDR‐GNB prevalence from <15% (30.9%), 15%–30% (43.6%) to >30% (16.4%). The frequency of screening for ESCR‐E, CRE, MDR‐Pa, and CRAb was 22%, 54%, 17%, and 24% for LT, respectively, and 18%, 36%, 16%, and 11% for KT. Screening time‐points were mainly at transplantation 100%, only one‐third following transplantation. Screening was always based on rectal swab cultures (100%); multi‐site sampling was reported in 40% of KT and 35% of LT. In LT clinical cases, 84%, 58%, 84%, and 40% of respondents reported TAP for prior infection/colonization with ESCR‐E, CRE, MDR‐Pa, and CRAb, respectively. In KT clinical cases, 55%, 39%, 87%, and 42% of respondents reported TAP use for prior infection/colonization with ESCR‐E, CRE, MDR‐Pa, and CRAb, respectively.ConclusionThere is a large heterogeneity in screening and management of MDR‐GNB carriage in LT and KT. image

Publisher

Wiley

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3